XML 113 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
 3 Months Ended 4 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance $ (6,252,747) $ (8,185,793) $ (15,297,513)   $ (15,297,513) $ (15,297,513) $ (15,297,513) $ (21,180,336)
Reduction of deferred underwriter fees     10,844,098       10,844,098  
Accretion of Class A ordinary shares to redemption value (1,084,311) (786,320) (3,568,966)   (4,355,287) (5,439,596)   (4,695,302)
Issuance of subscription shares 491,175 166,966 256,635          
Net income (loss) (338,050) 2,552,400 (420,047) $ 2,552,400 2,132,353 1,794,302 (34,727) 10,578,125
Balance (7,183,933) (6,252,747) (8,185,793) (6,252,747) (6,252,747) (7,183,933) (9,233,742) (15,297,513)
Conversion of class B shares to Class A shares            
Additional Paid-in Capital                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance 6,912,413 7,531,767  
Reduction of deferred underwriter fees     10,844,098       10,844,098  
Accretion of Class A ordinary shares to redemption value (1,084,311) (786,320) (3,568,966)        
Issuance of subscription shares 491,175 166,966 256,635          
Net income (loss)            
Balance 6,319,277 6,912,413 7,531,767 6,912,413 6,912,413 6,319,277 6,098,498
Conversion of class B shares to Class A shares              
Accumulated Deficit                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (13,165,959) (15,718,359) (15,298,312)   (15,298,312) (15,298,312) (15,298,312) (21,181,135)
Reduction of deferred underwriter fees              
Accretion of Class A ordinary shares to redemption value         (4,695,302)
Net income (loss) (338,050) 2,552,400 (420,047)       (34,727) 10,578,125
Balance $ (13,504,009) $ (13,165,959) $ (15,718,359) $ (13,165,959) $ (13,165,959) $ (13,504,009) (15,333,039) $ (15,298,312)
Conversion of class B shares to Class A shares              
Class A Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 0   0 0 0  
Balance (in Shares) 7,980,409 0
Class A Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares)    
Balance  
Reduction of deferred underwriter fees              
Accretion of Class A ordinary shares to redemption value              
Net income (loss)            
Balance (in Shares) 7,980,409 7,980,409  
Balance $ 799 $ 799 $ 799
Conversion of class B shares to Class A shares (in Shares) 7,980,409           7,980,409  
Conversion of class B shares to Class A shares $ 799           $ 799  
Class B Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409 7,980,409 7,980,409   7,980,409 7,980,409 7,980,409  
Balance (in Shares) 7,980,409 7,980,409 7,980,409 7,980,409 7,980,409 7,980,409 0 7,980,409
Class B Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409 7,980,409 7,980,409   7,980,409 7,980,409 7,980,409  
Balance $ 799 $ 799 $ 799   $ 799 $ 799 $ 799 $ 799
Reduction of deferred underwriter fees              
Accretion of Class A ordinary shares to redemption value              
Net income (loss)            
Balance (in Shares) 7,980,409 7,980,409 7,980,409 7,980,409   7,980,409
Balance $ 799 $ 799 $ 799 $ 799 $ 799
Conversion of class B shares to Class A shares (in Shares) (7,980,409)           (7,980,409)  
Conversion of class B shares to Class A shares $ (799)           $ (799)  
As Previously Reported [Member]                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (5,252,495) (8,734,659) (15,297,513)   (15,297,513) (15,297,513) (15,297,513)  
Reduction of deferred underwriter fees     10,844,098          
Accretion of Class A ordinary shares to redemption value (1,084,311) (786,320) (3,568,966)   (4,355,287) (5,439,596)    
Net income (loss) (4,605,843) 4,268,484 (712,278) 4,268,484 3,556,206 (1,049,638)    
Balance (10,942,649) (5,252,495) (8,734,659) (5,252,495) (5,252,495) (10,942,649)   (15,297,513)
Conversion of class B shares to Class A shares              
As Previously Reported [Member] | Additional Paid-in Capital                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance 6,488,812 7,275,132    
Reduction of deferred underwriter fees     10,844,098          
Accretion of Class A ordinary shares to redemption value (1,084,311) (786,320) (3,568,966)          
Balance 5,404,501 6,488,812 7,275,132 6,488,812 6,488,812 5,404,501  
As Previously Reported [Member] | Accumulated Deficit                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (11,742,106) (16,010,590) (15,298,312)   (15,298,312) (15,298,312) $ (15,298,312)  
Accretion of Class A ordinary shares to redemption value          
Net income (loss) (4,605,843) 4,268,484 (712,278)          
Balance $ (16,347,949) $ (11,742,106) $ (16,010,590) $ (11,742,106) $ (11,742,106) $ (16,347,949)   $ (15,298,312)
As Previously Reported [Member] | Class A Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409            
Balance (in Shares) 7,980,409 7,980,409 7,980,409    
As Previously Reported [Member] | Class A Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares)    
Balance    
Balance (in Shares) 7,980,409 7,980,409  
Balance $ 799 $ 799  
Conversion of class B shares to Class A shares (in Shares) 7,980,409              
Conversion of class B shares to Class A shares $ 799              
As Previously Reported [Member] | Class B Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409            
Balance (in Shares) 7,980,409 7,980,409 7,980,409    
As Previously Reported [Member] | Class B Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409 7,980,409 7,980,409   7,980,409 7,980,409 7,980,409  
Balance $ 799 $ 799 $ 799   $ 799 $ 799 $ 799  
Balance (in Shares) 7,980,409 7,980,409 7,980,409 7,980,409   7,980,409
Balance $ 799 $ 799 $ 799 $ 799   $ 799
Conversion of class B shares to Class A shares (in Shares) (7,980,409)              
Conversion of class B shares to Class A shares $ (799)              
Restatement Impacts [Member]                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (16,297,765) (14,748,647) (15,297,513)   (15,297,513) (15,297,513) (15,297,513)  
Issuance of subscription shares 491,175 166,966 256,635          
Net income (loss) 4,267,793 (1,716,084) 292,231          
Balance (11,538,797) (16,297,765) (14,748,647) (16,297,765) (16,297,765) (11,538,797)   (15,297,513)
Conversion of class B shares to Class A shares              
Restatement Impacts [Member] | Additional Paid-in Capital                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance 423,601 256,635    
Issuance of subscription shares 491,175 166,966 256,635          
Balance 914,776 423,601 256,635 423,601 423,601 914,776  
Restatement Impacts [Member] | Accumulated Deficit                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (16,722,165) (15,006,081) (15,298,312)   (15,298,312) (15,298,312) $ (15,298,312)  
Accretion of Class A ordinary shares to redemption value          
Net income (loss) 4,267,793 (1,716,084) 292,231          
Balance $ (12,454,372) $ (16,722,165) $ (15,006,081) $ (16,722,165) $ (16,722,165) $ (12,454,372)   $ (15,298,312)
Restatement Impacts [Member] | Class A Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares)    
Balance    
Balance (in Shares)  
Balance  
Restatement Impacts [Member] | Class B Ordinary Shares | Ordinary Shares                
Restatement of Previously Issued Financial Statements (Details) - Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit [Line Items]                
Balance (in Shares) 7,980,409 7,980,409 7,980,409   7,980,409 7,980,409 7,980,409  
Balance $ 799 $ 799 $ 799   $ 799 $ 799 $ 799  
Balance (in Shares) 7,980,409 7,980,409 7,980,409 7,980,409 7,980,409 7,980,409   7,980,409
Balance $ 799 $ 799 $ 799 $ 799 $ 799 $ 799   $ 799